September 17 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its CEO Ognyan Donev has acquired 2,926 shares in the company at a weighted average price per share of 3.4061 levs ($1.92/1.74 euro).